Breaking News

HHS Appoints Director of Center for Drug Evaluation and Research

Richard Pazdur to help guide CDER agenda to modernize the agency and streamline the approval process.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

HHS CDER Director

The U.S. Department of Health and Human Services (HHS) and the U.S. FDA, has appointed Richard Pazdur, M.D., as director of the Center for Drug Evaluation and Research (CDER). Pazdur is a 26-year veteran of the FDA and the founding director of its Oncology Center of Excellence.  Dr. Pazdur developed an integrated approach for cross-center coordination of oncology product review to help expedite the development of cancer therapies. He also led a series of initiatives that helped to streamline ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters